World J Emerg Med. 2016;7(4):250-254. doi: 10.5847/wjem.j.1920-8642.2016.04.002.
Amiodaron in atrial fibrillation: post coronary artery bypass graft.
World journal of emergency medicine
Paria Habibollahi, Shahrzad Hashemi Jam, Samad Shams Vahdati, Hamidreza Morteza Baghi, Hassan Amiri
Affiliations
Affiliations
- Pharmacology and Toxicology Department, Tabriz University of Medical Science, Tabriz, Iran.
- Emergency Medicine Research Team, Emergency Department, Tabriz University of Medical Science, Tabriz, Iran.
- Emergency Department, Iran University of Medical Science, Tehran, Iran.
PMID: 27942340
PMCID: PMC5143307 DOI: 10.5847/wjem.j.1920-8642.2016.04.002
Abstract
BACKGROUND: Atrial fibrilation (AF) is the most common complication following heart surgeries; it often occurs in patients after coronary artery bypass graft (CABG). The purpose of this review is to categorize prophylaxes or treatment by administration of Amiodaron in patients with CABG.
DATA RESOURCES: We searched google scholar, pubmed, and Cochrane Library databases (the period 1970-2010) for articles on Amiodaron in CABG and cardiac surgery. A total of 1 561 articles were identified, and 30 articles met the criteria and were enrolled in this review.
RESULTS: Most studies supported Amiodarone for prophylaxi purpose in patients who were performed with CABG; few papers supported Amiodaron as a drug for treating CABG. The prophylaxis can decrease the incidence rate of AF in CABG, but if it uses as a treatment, the side effect of Amiodaron will decrease because all of the patients will not get Amiodarone. In the other hand use of Amiodarone as a treatment does not influence the length of hospital stay significantly but these kinds of study are so few.
CONCLUSION: No appropriate therapeutic method has been defined for AF. At present, the common way of treating AF following cardiac surgery is mainly based on prophylaxis in medical books and references.
Keywords: Lateral position; Pulmonary aspiration; Semi-lateral position
Conflict of interest statement
The authors declare that there is no conflict of interest.
References
- Circulation. 2000 Sep 19;102(12):1382-7 - PubMed
- Am J Cardiol. 1974 Aug;34(2):215-23 - PubMed
- Ann Thorac Surg. 2007 Apr;83(4):1326-31 - PubMed
- Circulation. 2002 Jul 2;106(1):75-80 - PubMed
- N Engl J Med. 1997 Dec 18;337(25):1785-91 - PubMed
- Am Heart J. 1999 Jul;138(1 Pt 1):144-50 - PubMed
- Lancet. 1994 Aug 20;344(8921):493-8 - PubMed
- J Am Coll Cardiol. 1999 Aug;34(2):343-7 - PubMed
- Ann Intern Med. 1992 Jul 15;117(2):141-50 - PubMed
- Am J Cardiol. 2000 Feb 15;85(4):462-5 - PubMed
- N Engl J Med. 1995 Jul 13;333(2):77-82 - PubMed
- Am Heart J. 1991 Jan;121(1 Pt 1):89-95 - PubMed
- Eur Heart J. 1996 Jul;17 Suppl C:41-7 - PubMed
- J Am Coll Cardiol. 1992 Jan;19(1):169-73 - PubMed
- Eur Heart J. 1994 Oct;15(10):1396-402 - PubMed
- N Engl J Med. 1994 Sep 22;331(12):785-91 - PubMed
- J Cardiovasc Thorac Res. 2012;4(1):17-20 - PubMed
- Eur Heart J. 2006 Jul;27(13):1584-91 - PubMed
- N Engl J Med. 1987 Feb 19;316(8):455-66 - PubMed
- Ann Thorac Surg. 2008 Jan;85(1):28-32 - PubMed
- J Am Coll Cardiol. 2005 May 17;45(10):1723-8 - PubMed
- Am J Cardiol. 1985 Mar 1;55(6):696-702 - PubMed
- Am J Cardiol. 1984 Jan 1;53(1):93-8 - PubMed
- Eur Heart J. 1983 Mar;4(3):180-5 - PubMed
- Am J Cardiol. 1983 Dec 1;52(10 ):1214-8 - PubMed
- Int J Cardiol. 1992 Apr;35(1):77-85 - PubMed
- Ann Thorac Surg. 2000 Jan;69(1):300-6 - PubMed
- Br Heart J. 1993 Jul;70(1):56-60 - PubMed
Publication Types